Hocoma is positioned as the global leader in robotic and sensor-based devices for functional movement therapy, enhancing the rehabilitation landscape. Founded in 2000 and headquartered in Switzerland, Hocoma has etched its mark over the past two decades by deploying advanced technologies for movement rehabilitation across more than 70 countries. This global presence, in renowned rehabilitation hospitals and clinics, underscores its transformative impact on millions of lives.
The company has successfully integrated into the scientific and public domain, being featured in elite publications like The Lancet and Journal of NeuroEngineering and Rehabilitation, as well as mainstream media such as TechCrunch and The Oprah Magazine. Despite being a part of the DIH family, Hocoma continues to innovate in the Health Care, Health and Wellness, and Robotics industries.
Notably, there is no recent investment activity, which could be an area for potential growth and partnership exploration for investors.